SPY330.67-3.83 -1.15%
DIA277.12-1.78 -0.64%
IXIC10,724.87-185.41 -1.70%

Verastem Oncology Q4 EPS $(0.400) Beats $(0.450) Estimate, Sales $3.617M Miss $4.500M Estimate

Verastem Oncology (NASDAQ:VSTM) reported quarterly losses of $(0.400) per share which beat the analyst consensus estimate of $(0.450) by 11.11 percent. This is a 8.11 percent decrease over losses of $(0.370) per share

Benzinga · 05/07/2020 20:51

Verastem Oncology (NASDAQ:VSTM) reported quarterly losses of $(0.400) per share which beat the analyst consensus estimate of $(0.450) by 11.11 percent. This is a 8.11 percent decrease over losses of $(0.370) per share from the same period last year. The company reported quarterly sales of $3.617 million which missed the analyst consensus estimate of $4.500 million by 19.62 percent. This is a 198.93 percent increase over sales of $1.210 million the same period last year.